 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
May 17, 2019
Acucela
Robert J. Stevens joined the board of Acucela, a Seattle-based clinical-stage ophthalmology company focused on curing blindness. Stevens is chief technology officer at CorneaGen in Seattle. He has 33 years of ophthalmology experience, including product research and design. Acucela is a subsidiary of Kubota Pharmaceutical Holdings Co. of Tokyo.